NCT00000379|CompletedPhase 3
Fluoxetine vs EMDR to Treat Post-Traumatic Stress Disorder (PTSD)
Treatment of Outcomes of Fluoxetine vs EMDR in PTSD
Loading search results
Treatment of Outcomes of Fluoxetine vs EMDR in PTSD
Sponsor study identifier
NIH
Secondary identifiers
NIH
interventional
N/A
1 country
1
Study Start
January 1999
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
December 2003
Date type not reportedThis date has not been verified as actual or estimated.
The purpose of this study is to compare two treatments for post-traumatic stress disorder (PTSD): fluoxetine (an antidepressant) and Eye Movement Desensitization and Reprocessing (EMDR, a psychological treatment in which the patient is led through the memory of a traumatic experience in order to heal him/herself). There are a variety of therapies used to treat PTSD, but the effectiveness of medication alone vs an exposure treatment, such as EMDR, has not been tested. Patients will be assigned randomly (like tossing a coin) to one of three groups for 8 weeks of treatment. Group 1 will receive fluoxetine; Group 2 will receive EMDR; and Group 3 will receive inactive placebo. Patients will then stop treatment and have evaluations, including psychological tests, at the time treatment is stopped, 8 weeks later, and at 6 months. An individual may be eligible for this study if he/she: Has PTSD and is 18 to 65 years old.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2003
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1999
Date type not reportedThis date has not been verified as actual or estimated.
November 2, 1999
Actual (reported)November 3, 1999
Actual (reported)December 2003
Date type not reportedThis date has not been verified as actual or estimated.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
The Trauma Center
Brookline, Massachusetts, 02446, United States
Bessel Van Der Kolk, MD
First Submitted
November 2, 1999
First Posted
November 3, 1999
Study Start
January 1999
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
December 2003
Date type not reportedThis date has not been verified as actual or estimated.
Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
Last Updated
February 20, 2014
Record last verified: 2014-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: